ArticleBMC pediatrics2026
Analysis of clinical characteristics and risk factors for severe EBV infection in children-a single-center retrospective cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the clinical features and risk factors of severe Epstein-Barr virus (EBV) infection in children.
methodsA retrospective analysis of the medical records of 144 cases admitted to the PICU (Pediatric Intensive Care Unit) and pediatric general wards of Shanghai Children's Hospital from January 2019 to March 2024 for Epstein-Barr virus (EBV) infection was conducted. The cases were categorized into severe and IM (Infectious Mononucleosis) groups according to the presence or absence of organ dysfunction.
resultsThe children in the severe group exhibited elevated incidences of gastrointestinal symptoms, cervical lymph node enlargement, hepatomegaly, and gallbladder and bile duct involvement (P ≤ 0.05). The plasma EBV DNA copy number of children in the severe group was higher than that in the IM group. Additionally, hemoglobin levels, D-dimer levels, lymphocyte subsets, and cytokines IL (Interleukin)-10 and IFN (Interferon)-γ were statistically different between the two groups (all P ≤ 0.05). Independent risk factors for severe EBV infection were identified as hemoglobin, IFN-γ and D-dimer. The predicted AUC (Area Under Curve) for hemoglobin was 0.83, with a critical value of 11.1 g/dL (P = 0.02); for D-dimer, the AUC was 0.93, with a critical value of 2.4 mg/L (P = 0.04); and for IFN-γ, the AUC was 0.80, with a critical value of 243.7 pg/ml (P = 0.04).
conclusionThis study suggests that hemoglobin, IFN-γ and D-dimer may are risk factors for progression of EBV infection to severe disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.